Thursday, November 15, 2012

Kidney International - Table of Contents alert Volume 82 Issue 11


TABLE OF CONTENTS

Volume 82, Issue 11 (December 2012)

In this issue
In this Issue
Editorial
Journal Club
Commentaries
Review
Original Articles
Technical Notes
Nephrology Image
Make Your Diagnosis

Also new
AOP


Biomarker Services for Early and Sensitive Detection of Kidney Damage. Myriad RBM's Rat & Human KidneyMAP® panels enable drug developers to efficiently prioritize medicinal chemistry programs and accelerate decisions on pre-clinical and clinical trial protocols. Click Here to download our White Paper and receive 10% off your next order.
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Curing Kidney Disease

Thank you to all of you who came to visit the NPG booth at ASN in San Diego.

As part of the theme 'Curing Kidney Disease' here are some articles from Kidney International:

Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial


Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
 

In this Issue

Top

In this Issue

Kidney Int 2012 82: 1143; 10.1038/ki.2012.357

Full Text

Editorial

Top

Quality of reporting of randomization methodology in nephrology trials

Steven Fishbane, Azzour D Hazzan, Shayan Shirazian, Ezra Israel and Giovanni F Strippoli

Kidney Int 2012 82: 1144-1146; 10.1038/ki.2012.335

Full Text

Journal Club

Top

Journal Club

Kidney Int 2012 82: 1147-1148; 10.1038/ki.2012.358

Full Text

Commentaries

Top

Modulation of apoptosis by ischemic preconditioning: an emerging role for miR-21

Tarek M El-Achkar

Kidney Int 2012 82: 1149-1151; 10.1038/ki.2012.305

Abstract | Full Text

Strategies to reverse endothelial dysfunction in diabetic nephropathy

Shawn S Badal and Farhad R Danesh

Kidney Int 2012 82: 1151-1154; 10.1038/ki.2012.306

Abstract | Full Text

Lixivaptan: a vasopressin receptor antagonist for the treatment of hyponatremia

Mitchell H Rosner

Kidney Int 2012 82: 1154-1156; 10.1038/ki.2012.317

Abstract | Full Text

Review

Top

Sensing mechanisms involved in Ca2+ and Mg2+ homeostasis

Silvia Ferrè, Joost G J Hoenderop and René J M Bindels

Kidney Int 2012 82: 1157-1166; advance online publication, May 23, 2012; 10.1038/ki.2012.179

Abstract | Full Text

Original Articles

Top

Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21

Xialian Xu, Alison J Kriegel, Yong Liu, Kristie Usa, Domagoj Mladinov, Hong Liu, Yi Fang, Xiaoqiang Ding and Mingyu Liang

Kidney Int 2012 82: 1167-1175; advance online publication, July 11, 2012; 10.1038/ki.2012.241

Abstract | Full Text

Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice

Huifang Cheng, Hanmin Wang, Xiaofeng Fan, Paisit Paueksakon and Raymond C Harris

Kidney Int 2012 82: 1176-1183; advance online publication, July 11, 2012; 10.1038/ki.2012.248

Abstract | Full Text

Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention

Donald E Wesson, Chan-Hee Jo and Jan Simoni

Kidney Int 2012 82: 1184-1194; advance online publication, July 25, 2012; 10.1038/ki.2012.267

Abstract | Full Text

Endothelial pentraxin 3 contributes to murine ischemic acute kidney injury

Jianlin Chen, Martin M Matzuk, Xin J Zhou and Christopher Y Lu

Kidney Int 2012 82: 1195-1207; advance online publication, August 15, 2012; 10.1038/ki.2012.268

Abstract | Full Text

Greater variability in kidney function is associated with an increased risk of death

Ziyad Al-Aly, Sumitra Balasubramanian, Jay R McDonald, Jeffrey F Scherrer and Ann M O'Hare

Kidney Int 2012 82: 1208-1214; advance online publication, August 1, 2012; 10.1038/ki.2012.276

Abstract | Full Text

Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia

William T Abraham, Guy Decaux, Richard C Josiassen, Yoram Yagil, Nelson Kopyt, Hemant P Thacker, Massimo Mannelli, Daniel G Bichet and Cesare Orlandi the HARMONY Study Group

Kidney Int 2012 82: 1215-1222; advance online publication, August 29, 2012; 10.1038/ki.2012.274

Abstract | Full Text

Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia

William T Abraham, Johannes Hensen, Peter A Gross, Daniel G Bichet, Richard C Josiassen, DeoDatta S Chafekar and Cesare Orlandi for the LIBRA Study Group

Kidney Int 2012 82: 1223-1230; advance online publication, August 29, 2012; 10.1038/ki.2012.275

Abstract | Full Text

Technical Notes

Top

A reproducible mouse model of chronic allograft nephropathy with vasculopathy

Abolfazl Zarjou, Lingling Guo, Paul W Sanders, Roslyn B Mannon, Anupam Agarwal and James F George

Kidney Int 2012 82: 1231-1235; advance online publication, August 8, 2012; 10.1038/ki.2012.277

Abstract | Full Text

Nephrology Image

Top

Of veins, valves, and vascular access!

Prabir Roy-Chaudhury, Jenq-Shyong Chan, Timmy Lee, Meenakshi Mistry, Begoña Campos, Yang Wang and Rino Munda

Kidney Int 2012 82: 1236-1237; 10.1038/ki.2012.316

Full Text

Make Your Diagnosis

Top

The Case | Unusual cause of chronic renal failure with elevated liver enzymes

Ferruh Artunc, Friedhelm Hildebrandt and Kerstin Amann

Kidney Int 2012 82: 1239-1240; 10.1038/ki.2012.334

Full Text

Advertisement
Kidney International - New Impact Factor

The 2011 ISI impact factor for Kidney International is 6.606*, according to the ISI Journal Citation Reports®. This places Kidney International among the top 3 primary research journals in nephrology.

Submit your article today!

*2011 Journal Citation Reports® (Thomson Reuters, 2012)
 

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Kidney International. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: